Oxford Biomedica annual debt-to-equity ratio
2020
2021
2022
2023
2024
2025
Oxford Biomedica Debt-to-Equity Ratio Growth & History (OXB)
Oxford Biomedica's debt-to-equity ratio was 1.62 for fiscal 2025.
View full Oxford Biomedica company overviewOxford Biomedica annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 1.62 | −0.28 | −14.95% |
| 2024 | 2024-12-31 | 1.91 | 0.40 | +26.59% |
| 2023 | 2023-12-31 | 1.51 | 0.95 | +169.70% |
| 2022 | 2022-12-31 | 0.56 | 0.51 | +1019.92% |
| 2021 | 2021-12-31 | 0.05 | −0.07 | −59.40% |
| 2020 | 2020-12-31 | 0.12 | — | — |
Oxford Biomedica quarterly debt-to-equity ratio
Q4.24
Q2.25
Q4.25
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 1.62 | −0.28 | −14.95% |
| Q2 2025 | 2025-06-30 | 3.22 | — | — |
| Q4 2024 | 2024-12-31 | 1.91 | — | — |
Oxford Biomedica debt-to-equity ratio trends
Over the last five fiscal years, Oxford Biomedica's debt-to-equity ratio increased from 0.12 to 1.62, a change of 1.50. The latest reported quarter, Q4 2025, shows 1.62.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Oxford Biomedica source filings ↗